Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.857 | 14 | 2012 | 2018 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.857 | 14 | 2012 | 2018 | |||||||
|
0.672 | 0.320 | 6 | 52190541 | 3 prime UTR variant | C/T | snv | 6.2E-02 |
|
Digestive System Diseases; Neoplasms | 0.080 | 0.750 | 8 | 2012 | 2018 | |||||||
|
0.672 | 0.320 | 6 | 52190541 | 3 prime UTR variant | C/T | snv | 6.2E-02 |
|
Digestive System Diseases; Neoplasms | 0.080 | 0.750 | 8 | 2012 | 2018 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.070 | 0.857 | 7 | 2015 | 2020 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.060 | 1.000 | 6 | 2015 | 2017 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.060 | 1.000 | 6 | 2015 | 2017 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.060 | 1.000 | 6 | 2015 | 2017 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Digestive System Diseases; Neoplasms | 0.050 | 1.000 | 5 | 2014 | 2019 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Cardiovascular Diseases | 0.050 | 1.000 | 5 | 2015 | 2019 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Infections | 0.050 | 0.600 | 5 | 2013 | 2017 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Digestive System Diseases | 0.050 | 1.000 | 5 | 2008 | 2014 | |||||||
|
0.716 | 0.360 | 6 | 52187772 | missense variant | A/G | snv | 8.0E-06 | 7.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.040 | 1.000 | 4 | 2010 | 2018 | ||||||
|
0.716 | 0.360 | 6 | 52187772 | missense variant | A/G | snv | 8.0E-06 | 7.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.040 | 1.000 | 4 | 2010 | 2018 | ||||||
|
0.716 | 0.360 | 6 | 52187772 | missense variant | A/G | snv | 8.0E-06 | 7.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.040 | 1.000 | 4 | 2014 | 2018 | ||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2014 | 2016 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Musculoskeletal Diseases | 0.040 | 1.000 | 4 | 2019 | 2019 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2014 | 2016 | |||||||
|
0.672 | 0.320 | 6 | 52190541 | 3 prime UTR variant | C/T | snv | 6.2E-02 |
|
Cardiovascular Diseases | 0.040 | 1.000 | 4 | 2015 | 2016 | |||||||
|
0.716 | 0.360 | 6 | 52187772 | missense variant | A/G | snv | 8.0E-06 | 7.0E-06 |
|
0.030 | 1.000 | 3 | 2014 | 2018 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
0.030 | 1.000 | 3 | 2014 | 2017 | ||||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||||
|
0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 |
|
Stomatognathic Diseases | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||||
|
0.672 | 0.320 | 6 | 52190541 | 3 prime UTR variant | C/T | snv | 6.2E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.030 | 1.000 | 3 | 2015 | 2017 |